Dr. Christopher M. Spearman, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 649
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: Jefferson Medical College of Thomas Jefferson University
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
WI license 67906 · PA license MD466650
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Scott and Christie and Associates PC (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 649
- Services billed
- 3,399
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient complete exam of visual system | 514 | 511 |
| Imaging of optic nerve | 313 | 292 |
| Exam of visual field with extended testing | 291 | 272 |
| Photography of the retina | 246 | 241 |
| Established patient office or other outpatient visit, 20-29 minutes | 241 | 222 |
| Imaging of retina | 221 | 155 |
| Established patient office or other outpatient visit, 30-39 minutes | 208 | 174 |
| Measurement of corneal curvature and depth of eye | 130 | 86 |
| Removal of cataract with insertion of prosthetic lens | 105 | 53 |
| Injection of drug into eye | 44 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in Cranberry Township, PA | 649 |
| Prednisolone Acetate Other prescribers in Cranberry Township, PA | 191 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Cranberry Township, PA | 116 |
| Timolol Maleate Other prescribers in Cranberry Township, PA | 106 |
| Lumigan (bimatoprost) Other prescribers in Cranberry Township, PA | 78 |
| Cyclosporine Other prescribers in Cranberry Township, PA | 54 |
| Xiidra (lifitegrast) Other prescribers in Cranberry Township, PA | 51 |
| Rocklatan (netarsudil mesylat/latanoprost) Other prescribers in Cranberry Township, PA | 50 |
| Brimonidine Tartrate Other prescribers in Cranberry Township, PA | 47 |
| Tobramycin-Dexamethasone (tobramycin/dexamethasone) Other prescribers in Cranberry Township, PA | 44 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 106 payments worth $35,733 in total to this clinician.
| Sight Sciences, Inc. | $26,035 |
|---|---|
| Glaukos Corporation | $6,556 |
| Tarsus Pharmaceuticals, Inc. | $1,813 |
| Alcon Vision LLC | $944 |
| Bausch & Lomb Americas Inc. | $178 |
| AbbVie Inc. | $61.51 |
| Biotissue Holdings Inc. | $38.87 |
| New World Medical,inc. | $35.59 |
| Compensation for services other than consulting (speaking, faculty) | $21,578 |
|---|---|
| Consulting Fee | $7,100 |
| Food and Beverage | $3,833 |
| Travel and Lodging | $3,222 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sight Sciences, Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $7,500 |
| Sight Sciences, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $3,653 |
| Glaukos Corporation Aug 27, 2025 | Consulting Fee | $3,500 |
| Sight Sciences, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $2,600 |
| Sight Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $2,500 |
| Glaukos Corporation Nov 12, 2025 | Consulting Fee | $2,100 |
| Sight Sciences, Inc. May 29, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $2,000 |
| Sight Sciences, Inc. Mar 20, 2025 | Travel and Lodging OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology · travel to Wexford, PA | $1,645 |
| Tarsus Pharmaceuticals, Inc. Feb 19, 2025 | Consulting Fee | $1,500 |
| Sight Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $1,500 |
All 17 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Sight Sciences, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $2,600 |
| Glaukos Corporation Nov 12, 2025 | Consulting Fee | $2,100 |
| Sight Sciences, Inc. Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $325 |
| Glaukos Corporation Aug 27, 2025 | Consulting Fee | $3,500 |
| Sight Sciences, Inc. Aug 27, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $750 |
| Sight Sciences, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $3,653 |
| Sight Sciences, Inc. Aug 21, 2025 | Travel and Lodging OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology · travel to Wexford, PA | $1,401 |
| Sight Sciences, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $500 |
| Sight Sciences, Inc. May 29, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $2,000 |
| Sight Sciences, Inc. May 29, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $250 |
| Sight Sciences, Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $7,500 |
| Sight Sciences, Inc. Mar 20, 2025 | Travel and Lodging OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology · travel to Wexford, PA | $1,645 |
| Sight Sciences, Inc. Mar 20, 2025 | Travel and Lodging OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology · travel to Wexford, PA | $94.86 |
| Sight Sciences, Inc. Mar 20, 2025 | Travel and Lodging OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology · travel to Wexford, PA | $80.00 |
| Tarsus Pharmaceuticals, Inc. Feb 19, 2025 | Consulting Fee | $1,500 |
| Sight Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $2,500 |
| Sight Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) OMNI SURGICAL SYSTEM; SION SURGICAL INSTRUMENT · Ophthalmology | $1,500 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 5 companies. The companies reported $272,269 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment
Oyster Point Pharma, Inc. · Terminated · NCT06400511 - A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
Bausch & Lomb Americas Inc. - The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial
Alcon Research LLC - Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
AbbVie Inc. · Completed · NCT03891446 - Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
AbbVie Inc. - Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects …
Glaukos Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.